Open Trials

 

 

 

Ovar

 

 

AGO-OVAR 2.29

Atezolizumab in combination with Bevacizumab and Chemotherapy versus Bevacizumab and Chemotherapy in recurrent ovarian cancer - a randomized Phase III trial

 

   

Download

AGO-OVAR 2.29 German Synopsis>>

AGO-OVAR 2.31 / OReO

A Phase IIIb, Randomised, Double-blind, Placebo-controlled, Multicentre Study of Olaparib Maintenance Retreatment in Patients with Epithelial Ovarian Cancer Previously Treated With a PARPi and Responding to Repeat Platinum Chemotherapy (OReO)

 

 

 

Download

OReO German Synopsis>>

AGO-OVAR 2.32

Trabectedin/PLD versus continuation of platinum-based chemotherapy in patients with disease stabilization and no symptom benefit under platinum-based chemotherapy for recurrent ovarian cancer

 

 

Download

AGO-OVAR 2.32 German Synopsis>>

AGO-OVAR 2.33 / ANITA

A phase III randomized, double-blinded trial of platinum-based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal or peritoneal cancer and platinum treatment-free interval (TFIp) >6 months

 

 

 

Download

AGO-OVAR 2.33 German Synopsis>>

     

Ovar / Endometrium / Cervix

 

 

 

AtTEnd - Atezolizumab in Endometrial cancer

Phase III double-blind randomized placebo controlled trial of Atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer

 

 

Download

AtTEnd German Synopsis>>

AGO-ZX 3 / BEATcc

A Randomized Phase III Trial of Platinum Chemotherapy plus Paclitaxel with Bevacizumab and Atezolizumab versus Platinum Chemotherapy plus Paclitaxel and Bevacizumab in Metastatic (stage IVB), Persistent, or Recurrent Carcinoma of the Cervix

 

   

Download

BEATcc German Synopsis>>

 

 

Clinical trials in surgical settings 

 

 

AGO-OVAR OP.6 ECLAT

Pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence. A multicenter, prospective randomized controlled trial

 

 

 

Download

ECLAT German Synopsis>>

 

 

 

     

 

   

 

   

 

 

Deutsche Version | Sitemap | Search | Imprint | Data Protection | Contact

© 2011 AGO Research GmbH | Admin-Login | Webdesign Hamburg